Thimble Point Acquisition Corp Cl A (THMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | THMA | KRRO | ACRV | ||
| Company | Thimble Point Acquisition Corp Cl A | Korro Bio Inc | Acrivon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.15 | 8.36 | 2.33 | ||
| High | 9.33 | 8.59 | 2.40 | ||
| Low | 9.15 | 8.14 | 2.31 | ||
| Latest | 9.30 | 8.41 | 2.39 | ||
| Change | +0.18 | +0.01 | +0.07 | ||
| % Change | +1.93% | +0.12% | +3.02% | ||
| Volume | 700 | 80,400 | 88,800 | ||
| 20-Day Average Volume | 281,600 | 355,400 | 460,135 | ||
| Previous Close | 9.12 | 8.40 | 2.32 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 9.83 | 7.27 | 2.40 | ||
| 20-Day Raw Stochastic | 26.62% | 88.42% | 44.26% | ||
| 20-Day Relative Strength | 23.36 | 35.02 | 53.76 | ||
| Weighted Alpha | -9.39 | -3.24 | +10.19 | ||
| Today's Opinion | N/A | 72% Sell | 80% Buy | ||
| Previous Opinion | N/A | 56% Sell | 80% Buy | ||
| Last Month's Opinion | N/A | 24% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.34% since 11/26/21 | +6.32% since 12/17/25 | +3.46% since 12/17/25 | ||
| Low | 9.01 on 12/02/21 | 7.72 on 12/18/25 | 2.12 on 12/19/25 | ||
| High | 10.10 on 11/29/21 | 8.59 on 12/24/25 | 2.44 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | -6.72% since 11/03/21 | +42.54% since 11/24/25 | +1.27% since 11/24/25 | ||
| Low | 9.01 on 12/02/21 | 5.20 on 12/02/25 | 2.12 on 12/19/25 | ||
| High | 10.10 on 11/29/21 | 8.83 on 12/12/25 | 2.73 on 12/11/25 | ||
| 3-Month | |||||
| %Chg | -6.06% since 09/03/21 | -78.17% since 09/24/25 | +53.21% since 09/24/25 | ||
| Low | 9.01 on 12/02/21 | 5.20 on 12/02/25 | 1.51 on 09/25/25 | ||
| High | 10.10 on 11/29/21 | 55.89 on 10/16/25 | 2.73 on 12/11/25 | ||
| 6-Month | |||||
| %Chg | -4.12% since 06/03/21 | -33.73% since 06/24/25 | +92.74% since 06/24/25 | ||
| Low | 9.01 on 12/02/21 | 5.20 on 12/02/25 | 1.15 on 07/01/25 | ||
| High | 10.10 on 11/29/21 | 55.89 on 10/16/25 | 2.73 on 12/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 76,361 | 79,105 | 73,208 | ||
| Shares Outstanding, K | 8,211 | 9,417 | 31,555 | ||
| Annual Sales | 0 | 2,270,000 | 0 | ||
| Annual Net Income | 0 | -83,580,000 | -80,560,000 | ||
| Last Quarter Sales | 0 | 1,090,000 | 0 | ||
| Last Quarter Net Income | 5,830,000 | -18,060,000 | -18,230,000 | ||
| 60-Month Beta | N/A | 3.03 | 1.75 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/05/21 | -1.92 on 11/12/25 | -0.47 on 11/13/25 | ||
| Latest Earnings Date | 01/01/70 | 03/17/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||